Effects of Intracellular Glucopenia on Pulsatile Growth Hormone Secretion: Mediation in Part by Somatostatin*
- 1 September 1985
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 117 (3), 1132-1138
- https://doi.org/10.1210/endo-117-3-1132
Abstract
The effects of 2-deoxy-D-glucose (2DG)-induced intracellular glucoprivation on GH [growth hormone], insulin and glucose secretory dynamics were examined in freely moving rats bearing chronic intracerebroventricular and intracardiac venous cannulae. I.v. administration of 2DG (400 mg/kg) caused a severe suppression in amplitude and duration of spontaneous GH surges; plasma GH levels remained significantly depressed for at least 5 h in the presence of marked hyperglycemia. Plasma insulin levels were unchanged. Central administration of a low dose of 2DG (8 mg/10 .mu.l) also markedly attenuated GH pulse amplitude and raised plasma glucose levels, but this low dose was without effect when injected peripherally, suggesting a central site of action. To elucidate the mechanism(s) mediating the GH suppression response to insufficient glucose, the involvement of the 2 hypothalamic GH-regulatory peptides, somatostatin (SRIF) and GH-releasing factor (GRF) was assessed. Passive immunization of 2DG-treated rats with a specific SRIF antiserum (AS) caused an initial surge of GH release and significant elevation of both trough and mean 6-h plasma GH levels, compared to 2DG-normal sheep serum controls. However, SRIF AS failed to restore the amplitude of GH pulses to normal levels. Adminstration of 3 i.v. boluses of human GRF (10 .mu.g), at 90-min intervals, to 2DG-treated rats resulted in GH release which was variable and time dependent; the magnitude of the 1st response (1 h after 2DG injection) was significantly less than that of the other 2. Immunoneutralization with SRIF AS eliminnated this difference and significantly enhanced human GRF-induced GH release. Intracellular glucopenia is a potent inhibitor of pulsatile GH secretion in the rat, and this response is mediated, in part by an increase in SRIF release. While the present findings are compatible with the hypothesis that glucoprivation induces an acute SRIF release, only a partial role for SRIF is indicated in this response. The longer lasting suppression of GH pulses observed after glucose deprivation may be due to decreased output of GRF from the hypothalamus.This publication has 17 references indexed in Scilit:
- EVIDENCE FOR AUTOREGULATION OF GROWTH HORMONE SECRETION VIA THE CENTRAL NERVOUS SYSTEMEndocrinology, 1980
- Naloxone inhibits prolactin and growth hormone release induced by intracellular glucopenia in the ratsLife Sciences, 1980
- Solid phase synthesis of somatostatin-28Biochemical and Biophysical Research Communications, 1980
- Effects of Prolonged Food Deprivation on the Ultradian Growth Hormone Rhythm and Immunoreactive Somatostatin Tissue Levels in the Rat*Endocrinology, 1979
- Antiserum to Somatostatin Reverses Starvation-Induced Inhibition of Growth Hormone but Not Insulin Secretion*Endocrinology, 1978
- EFFECTS OF INHIBITORS OF CATECHOLAMINE SYNTHESIS AND CATECHOLAMINE AGONISTS ON MORPHINE- AND HYPOGLYCAEMIA-INDUCED RELEASE OF GROWTH HORMONE IN THE RATJournal of Endocrinology, 1978
- Ultradian Growth Hormone Rhythm in the Rat: Effects of Feeding, Hyperglycemia, and Insulin-Induced HypoglycemiaEndocrinology, 1976
- Hypoglycemia: A Potent Stimulus to Secretion of Growth HormoneScience, 1963
- SECRETION OF HUMAN GROWTH HORMONE - PHYSIOLOGIC AND EXPERIMENTAL MODIFICATION1963
- Effects of 2-Deoxyglucose on Blood Glucose Levels in the Rat.Experimental Biology and Medicine, 1959